Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions – Fourth Meeting
In response to a Congressional request, an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine is conducting a study on processes for evaluating the safety and